[VIEW] agent=Structured Finance Lead | scenario_id=21 | rounds=20

--- Round 0 ---
[R0.1] Structured Finance Lead (speak, public): Good morning, everyone. To decide whether we're ready to move forward with the Q2 2026 securitization of our prime auto-loan portfolio, I need to get a better understanding of the current portfolio performance and any key eligibility constraints that could impact our pool. Can we start with a review of the portfolio's credit quality and any concerns the Credit Risk Officer might have?
[R0.2] Credit Risk Officer (speak, public): The current portfolio has a weighted-average FICO score of 742 and a new-vehicle share of 62%. The weighted-average APR is 6.8%, and the weighted-average term is 64 months. Recent performance metrics show 30+ DPD at 1.35% and an annualized net loss of 1.10%. Our securitization eligibility overlays include a max original LTV of 125% and a max term of 84 months. The CECL model validation was completed in November 2025, although we do have one high finding still open.
[R0.3] Capital Planning Manager (speak, public): Thank you for the update, Credit Risk Officer. Based on the information provided, the portfolio appears to be of good quality. I'd like to build on this by discussing the capital, accounting, and liquidity implications. We've estimated an RWA relief of $860 million and a CET1 uplift of 18 basis points from this transaction. Additionally, we expect a reduction in projected 30-day net outflows by $210 million, which positively impacts our internal LCR, currently set at a 110% floor. Can you provide more details on the intended structure and size of the securitization, Structured Finance Lead?

--- Round 1 ---
[R1.1] Structured Finance Lead (speak, public): The planned issuance size is $1,250,000,000 with a senior tranche share of 78%, a mezzanine tranche share of 12%, and a residual share of 10%. We're targeting pricing on April 28, 2026, and settlement on May 20, 2026. The initial AAA spread is currently being discussed around SOFR+105 bps, with a duration of 1.9 years. We've also planned an interest rate hedge with a notional of $900,000,000 and an estimated hedge cost of 6 bps. I'd like to understand the capital benefits better and any internal constraints we should be aware of as we move forward with this transaction.
[R1.2] Credit Risk Officer (speak, public): To ensure we're on solid ground with this securitization, I'd like to clarify the disclosure and retention obligations we're planning to adhere to, as well as any specific accounting constraints that could affect how we construct the pool and the representations we make. Additionally, are there any internal profitability thresholds or pricing boundaries that we should be aware of as we structure this deal?
[R1.3] Capital Planning Manager (speak, public): To ensure we're on track with our capital planning objectives, I'd like to confirm that the planned structure aligns with our internal return hurdles and that we're not overlooking any potential accounting or regulatory constraints. Structured Finance Lead, can you provide more details on the hedge structure and any assumptions regarding the sale accounting treatment? Additionally, have we received any feedback from potential investors that could impact our pricing or deal structure?

--- Round 2 ---
[R2.1] Structured Finance Lead (speak, public): To address the concerns and questions raised, I'd like to provide more context on the hedge structure and our assumptions regarding sale accounting treatment. We've planned an interest rate swap with a notional of $900,000,000 to hedge the senior tranche, which constitutes about 92% of the total issuance size. We're assuming that the transaction will qualify for sale accounting treatment under ASC 860, given that we're planning to transfer the assets to a consolidated VIE and obtain true sale opinions. Regarding investor feedback, we've had preliminary discussions indicating strong interest, with soft-circle indications totaling $2,800,000,000. However, I'd like to hear more about the internal return hurdles and any specific accounting or regulatory constraints we need to be mindful of.
[R2.2] Credit Risk Officer (speak, public): I've received some of the information I was looking for, but I'd like to reiterate the importance of understanding the disclosure and retention obligations for this securitization. Additionally, could you clarify if there are any internal profitability thresholds that could influence our deal structuring or credit standards? I'd also appreciate any updates on the status of addressing the high finding from the CECL model validation.
[R2.3] Capital Planning Manager (speak, public): To ensure we're on track with our capital planning objectives, I'd like to clarify the expected gain-on-sale and confirm that we're within our internal cost budget for this transaction. Structured Finance Lead, can you confirm if the expected gain-on-sale of $6,400,000 is still valid given the current pricing discussions? Additionally, I'd appreciate an update on the status of our pre-clear memo due on April 10, 2026, and any feedback from our last supervisory check-in.

--- Round 3 ---
[R3.1] Structured Finance Lead (speak, public): To address the remaining concerns, I'd like to provide an update on the gain-on-sale and the pre-clear memo. The expected gain-on-sale of $6,400,000 is still valid based on current pricing discussions. Our team is working on finalizing the pre-clear memo, which is due on April 10, 2026. Additionally, we've received positive feedback from our last supervisory check-in, with no major concerns raised regarding our securitization plans. I'd like to confirm that we're aligned on the transaction's alignment with our internal return hurdles and any specific accounting or regulatory constraints.
[R3.2] Credit Risk Officer (speak, public): I've gathered some of the necessary information, but I still need clarification on the disclosure and retention obligations for this securitization. Additionally, could you confirm if there are any internal profitability thresholds that could influence our deal structuring or credit standards? I'd also appreciate an update on the status of addressing the high finding from the CECL model validation.
[R3.3] Capital Planning Manager (speak, public): To move forward, I'd like to summarize the key points discussed so far and assess if we're aligned on the transaction's implications. We've discussed the portfolio's credit quality, the planned structure and size of the securitization, and the capital, accounting, and liquidity implications. Structured Finance Lead, can you confirm if there are any updates on the hedge execution and if the expected gain-on-sale remains valid? Credit Risk Officer, could you provide an update on the status of addressing the high finding from the CECL model validation and any implications for our disclosure and retention obligations?

--- Round 4 ---
[R4.1] Structured Finance Lead (speak, public): To summarize, we've discussed the portfolio's credit quality, the planned structure and size of the securitization, and the capital, accounting, and liquidity implications. Credit Risk Officer, you've highlighted the importance of understanding disclosure and retention obligations, and you've raised concerns about internal profitability thresholds and the status of addressing the high finding from the CECL model validation. Capital Planning Manager, you've provided insights into the capital benefits and confirmed the expected gain-on-sale. To move forward, I'd like to confirm that we're aligned on the transaction's implications and assess if there are any remaining concerns or updates needed from each of your perspectives.
[R4.2] Credit Risk Officer (speak, public): To finalize my assessment, I'd like to confirm that we're aligned on the disclosure and retention obligations for this securitization. Additionally, could you provide an update on the status of addressing the high finding from the CECL model validation? Based on the information gathered, I'll be able to provide a final recommendation on whether to proceed with the Q2 2026 securitization.
[R4.3] Capital Planning Manager (speak, public): To summarize the key points and assess our alignment on the transaction's implications, we've discussed the portfolio's credit quality, the planned structure and size of the securitization, and the capital, accounting, and liquidity implications. We've estimated an RWA relief of $860 million and a CET1 uplift of 18 basis points, along with a reduction in projected 30-day net outflows by $210 million. The expected gain-on-sale is $6,400,000, and we're working towards finalizing the pre-clear memo by April 10, 2026. I'd like to confirm that we're aligned on the transaction's alignment with our internal return hurdles and any specific accounting or regulatory constraints. If there are no further updates or concerns, I believe we have a solid foundation to move forward with the Q2 2026 securitization.

--- Round 5 ---
[R5.1] Structured Finance Lead (speak, public): To finalize our discussion, I'd like to summarize the key points and assess our alignment on the transaction's implications. We've discussed the portfolio's credit quality, the planned structure and size of the securitization, and the capital, accounting, and liquidity implications. Credit Risk Officer, you've highlighted the importance of understanding disclosure and retention obligations, and you've raised concerns about internal profitability thresholds and the status of addressing the high finding from the CECL model validation. Capital Planning Manager, you've provided insights into the capital benefits and confirmed the expected gain-on-sale. Based on the information gathered, I believe we have a solid foundation to move forward with the Q2 2026 securitization. Let's confirm if there are any remaining concerns or updates needed from each of your perspectives.
[R5.2] Credit Risk Officer (speak, public): To finalize my assessment, I've gathered sufficient information on the planned securitization structure and its implications. Based on the discussions, I recommend proceeding with the Q2 2026 securitization, given the portfolio's credit quality and the transaction's alignment with our capital planning objectives. However, I emphasize the importance of addressing the outstanding high finding from the CECL model validation and ensuring compliance with disclosure and retention obligations. I believe we have a solid foundation to move forward, provided we continue to monitor and address any potential credit or repurchase exposure.
[R5.3] Capital Planning Manager (speak, public): To finalize our discussion, I'd like to summarize the key points and assess our alignment on the transaction's implications. We've discussed the portfolio's credit quality, the planned structure and size of the securitization, and the capital, accounting, and liquidity implications. We've estimated an RWA relief of $860 million and a CET1 uplift of 18 basis points, along with a reduction in projected 30-day net outflows by $210 million. The expected gain-on-sale is $6,400,000, and we're working towards finalizing the pre-clear memo by April 10, 2026. I believe we have a solid foundation to move forward with the Q2 2026 securitization, provided we continue to monitor and address any potential accounting, regulatory, or credit concerns. If there are no further updates or concerns, I'm inclined to recommend proceeding with the transaction.

--- Round 6 ---
[R6.1] Structured Finance Lead (speak, public): Based on the discussions and the information gathered, I believe we have a solid foundation to move forward with the Q2 2026 securitization. Credit Risk Officer and Capital Planning Manager, your insights have been invaluable in helping us assess the transaction's implications. To confirm, we'll proceed with the planned issuance size of $1,250,000,000 and the proposed structure. We'll continue to monitor the portfolio's credit quality and address any outstanding concerns, including the high finding from the CECL model validation. With the current market conditions and investor interest, I'm inclined to recommend proceeding with the transaction. Let's finalize the preparations and move forward with the securitization.
[R6.2] Credit Risk Officer (leave, public): 
[R6.3] Capital Planning Manager (speak, public): I believe we have a solid foundation to move forward with the Q2 2026 securitization. Let's finalize the preparations and proceed with the transaction as planned.

--- Round 7 ---
[R7.1] Structured Finance Lead (leave, public): 
[R7.2] Credit Risk Officer (leave, public): 
[R7.3] Capital Planning Manager (leave, public): 

--- Round 8 ---
[R8.1] Structured Finance Lead (leave, public): 
[R8.2] Credit Risk Officer (leave, public): 
[R8.3] Capital Planning Manager (leave, public): 

--- Round 9 ---
[R9.1] Structured Finance Lead (leave, public): 
[R9.2] Credit Risk Officer (leave, public): 
[R9.3] Capital Planning Manager (leave, public): 

--- Round 10 ---
[R10.1] Structured Finance Lead (leave, public): 
[R10.2] Credit Risk Officer (leave, public): 
[R10.3] Capital Planning Manager (leave, public): 

--- Round 11 ---
[R11.1] Structured Finance Lead (leave, public): 
[R11.2] Credit Risk Officer (leave, public): 
[R11.3] Capital Planning Manager (leave, public): 

--- Round 12 ---
[R12.1] Structured Finance Lead (leave, public): 
[R12.2] Credit Risk Officer (leave, public): 
[R12.3] Capital Planning Manager (leave, public): 

--- Round 13 ---
[R13.1] Structured Finance Lead (leave, public): 
[R13.2] Credit Risk Officer (leave, public): 
[R13.3] Capital Planning Manager (leave, public): 

--- Round 14 ---
[R14.1] Structured Finance Lead (leave, public): 
[R14.2] Credit Risk Officer (leave, public): 
[R14.3] Capital Planning Manager (leave, public): 

--- Round 15 ---
[R15.1] Structured Finance Lead (leave, public): 
[R15.2] Credit Risk Officer (leave, public): 
[R15.3] Capital Planning Manager (leave, public): 

--- Round 16 ---
[R16.1] Structured Finance Lead (leave, public): 
[R16.2] Credit Risk Officer (leave, public): 
[R16.3] Capital Planning Manager (leave, public): 

--- Round 17 ---
[R17.1] Structured Finance Lead (leave, public): 
[R17.2] Credit Risk Officer (leave, public): 
[R17.3] Capital Planning Manager (leave, public): 

--- Round 18 ---
[R18.1] Structured Finance Lead (leave, public): 
[R18.2] Credit Risk Officer (leave, public): 
[R18.3] Capital Planning Manager (leave, public): 

--- Round 19 ---
[R19.1] Structured Finance Lead (leave, public): 
[R19.2] Credit Risk Officer (leave, public): 
[R19.3] Capital Planning Manager (leave, public): 

